Recent Articles

Allergan plc Ordinary Shares: What Is AGN Getting for Its Billion Dollars?

Allergen (AGN) is in a buying mood, and can afford to buy Tobira (TBRA). But, that doesn't mean there's a big payback for the investment. More 

Allergan plc Ordinary Shares (AGN) Up on $639M Buyout of Vitae Pharmaceuticals Inc (VTAE)

Allergan plc Ordinary Shares (NYSE:AGN) is buying Vitae Pharmaceuticals Inc. (NASDAQ:VTAE) to ramp up its dermatology treatment offerings. More 

GW Pharmaceuticals PLC- ADR (GWPH) Boards the Buyout Rumor Mill

GW Pharma (GWPH) is allegedly working with an investment bank after several companies expressed interest in a transaction. More 

PFE, AZN: Pfizer Inc. to Buy AstraZeneca plc (ADR)’s Antibiotic Business

Pfizer (PFE) has announced that it will be acquiring part of AstraZeneca's (AZN) antibiotic business outside the US for $725 million. More 

7 Stocks the Smart Money Loves … Or Hates

What is the smart money buying and selling lately? A look at the newest opinions on stocks like Apple, Facebook ... and an Irish aircraft leaser? More 

Why Allergan plc Ordinary Shares (AGN), AMN Healthcare Services, Inc. (AHS) and Bristol-Myers Squibb Co (BMY) Are 3 of Today’s Worst Stocks

Owners of Bristol-Myers Squibb (BMY), Allergan (AGN) and AMN Healthcare Services (AHS) are wishing the weekend lasted one more day today. More 

Allergan Plc: Will the Downtrend Continue for AGN Stock?

Despite chatter of a biotech acquisition and earnings Monday morning, the options market in AGN stock suggests normal event risk next week. More